Journal
HUMAN VACCINES & IMMUNOTHERAPEUTICS
Volume 17, Issue 12, Pages 5439-5446Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21645515.2021.2007709
Keywords
Human papillomavirus infection; cervical cancer screening; prevalence survey; genotype distribution; general population; China
Categories
Funding
- Xi'an Health Commission [2020yb40]
Ask authors/readers for more resources
The study investigated the molecular epidemiology of HPV infection among women in Xi'an, China, finding an overall prevalence of 13.5%. High-risk HPV, low-risk HPV, and mixed HPV infection rates were 10.1%, 2.2%, and 1.3% respectively. HPV genotype distribution varied by region and age.
Cervical cancer is the fourth most common cancer among women worldwide in terms of both incidence and mortality. Persistent infection with high-risk human papillomavirus (HPV) has been identified as a cause of cervical intraepithelial neoplasia and invasive cervical cancer. The distribution of human papillomavirus genotypes varies regionally. To acquire baseline data on the population-based prevalence and genotype distribution of HPV infection, we investigated the molecular epidemiology of HPV infection among women in Xi'an, China. The study was conducted from September 2018 to December 2020. A total of 14,655 women aged 30-65 years were screened. The overall prevalence of HPV infection was 13.5% (95% confidence interval [CI]: 13.0-14.1%), with 10.4% of participants being positive for a single HPV type and 3.1% being positive for multiple HPV types. The prevalence of high-risk HPV (HR-HPV), low-risk HPV (LR-HPV) and mixed HPV infection was 10.1% (95% CI: 9.6-10.5%), 2.2% (95% CI: 2.0-2.4%), and 1.3% (95% CI: 1.1-1.5%), respectively. The five most frequently detected HR-HPV types were types 52 (2.6%), 16 (1.9%), 53 (1.8%), 58 (1.4%), and 51 (0.9%). The most frequently detected LR-HPV type was HPV-42 (1.1%). The prevalence and HPV genotype distribution varied by region and age. Age-specific HPV prevalence peaked in the over 60 years age group (18.8%), and Beilin District had the highest HPV prevalence (18.1%). The results of this first population-based study provide a reference for HPV-based cervical cancer screening and HPV vaccination programs in Xi'an.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available